AKR1B1 and diabetes mellitus: Given that lens opacification is a significant side effect of diabetes in this species, it is hoped that this molecule can be used more widely to prevent cataract formation in dogs affected by diabetes mellitus and potentially humans with aldose-reductase-associated diabetic pathology such as diabetic retinopathy.